Free Trial

Align Technology (ALGN) Stock Forecast & Price Target

Align Technology logo
$211.06 -2.52 (-1.18%)
(As of 12/20/2024 05:40 PM ET)

Align Technology - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
2
Hold
4
Buy
6

Based on 12 Wall Street analysts who have issued ratings for Align Technology in the last 12 months, the stock has a consensus rating of "Hold." Out of the 12 analysts, 2 have given a sell rating, 4 have given a hold rating, and 6 have given a buy rating for ALGN.

Consensus Price Target

$271.20
28.49% Upside
According to the 12 analysts' twelve-month price targets for Align Technology, the average price target is $271.20. The highest price target for ALGN is $320.00, while the lowest price target for ALGN is $206.00. The average price target represents a forecasted upside of 28.49% from the current price of $211.06.
Get the Latest News and Ratings for ALGN and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Align Technology and its competitors.

Sign Up

ALGN Analyst Ratings Over Time

TypeCurrent Forecast
12/23/23 to 12/22/24
1 Month Ago
11/23/23 to 11/22/24
3 Months Ago
9/24/23 to 9/23/24
1 Year Ago
12/23/22 to 12/23/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
6 Buy rating(s)
5 Buy rating(s)
5 Buy rating(s)
7 Buy rating(s)
Hold
4 Hold rating(s)
4 Hold rating(s)
3 Hold rating(s)
2 Hold rating(s)
Sell
2 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$271.20$276.38$306.88$325.60
Forecasted Upside28.49% Upside22.35% Upside21.22% Upside19.76% Upside
Consensus Rating
Hold
Hold
Hold
Moderate Buy

ALGN Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ALGN Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Align Technology Stock vs. The Competition

TypeAlign TechnologyMedical CompaniesS&P 500
Consensus Rating Score
2.33
2.81
2.51
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside28.49% Upside25,827.32% Upside14.53% Upside
News Sentiment Rating
Positive News

See Recent ALGN News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
12/13/2024Bank of America
3 of 5 stars
 Boost TargetUnderperform ➝ Underperform$200.00 ➝ $206.00-12.37%
12/4/2024Mizuho
3 of 5 stars
S. Valiquette
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$295.00+26.06%
11/4/2024Needham & Company LLC
2 of 5 stars
D. Saxon
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold
10/24/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight ➝ Overweight$310.00 ➝ $280.00+25.85%
10/24/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$285.00 ➝ $275.00+23.61%
10/24/2024Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$270.00 ➝ $250.00+12.38%
10/24/2024Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight ➝ Overweight$285.00 ➝ $275.00+24.36%
10/24/2024Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$325.00 ➝ $276.00+32.91%
6/4/2024OTR Global
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingPositive ➝ Mixed
4/15/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$280.00 ➝ $320.00+2.31%
2/26/2024Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Cherny
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform
2/26/2024Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageMarket Perform$310.00-2.17%
2/2/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetSell ➝ Sell$197.00 ➝ $225.00-17.34%
8/30/2023HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$450.00+22.41%
7/27/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$367.00 ➝ $400.00+17.70%
4/27/2023VNET Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMaintains
3/23/2023CICC Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageMarket Perform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 05:57 PM ET.


ALGN Forecast - Frequently Asked Questions

According to the research reports of 12 Wall Street equities research analysts, the average twelve-month stock price forecast for Align Technology is $271.20, with a high forecast of $320.00 and a low forecast of $206.00.

12 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Align Technology in the last twelve months. There are currently 2 sell ratings, 4 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" ALGN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ALGN, but not buy additional shares or sell existing shares.

According to analysts, Align Technology's stock has a predicted upside of 28.49% based on their 12-month stock forecasts.

Align Technology has been rated by research analysts at Bank of America, Evercore ISI, Mizuho, Morgan Stanley, Needham & Company LLC, Piper Sandler, Robert W. Baird, and Stifel Nicolaus in the past 90 days.

Analysts like Align Technology less than other "medical" companies. The consensus rating for Align Technology is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how ALGN compares to other companies.


This page (NASDAQ:ALGN) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners